![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Immunic CEO on key MS trial data coming in April (Proactive Investors) View |
![]() |
Immunic CMO on key ECTRIMS highlights and MS research (Proactive Investors) View |
![]() |
Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones (Proactive Investors) View |
![]() |
Immunic reports successful 2023 and prepares for key 2025 milestones (Proactive Investors) View |
![]() |
Immunic CEO details progress following productive third quarter (Proactive Investors) View |
![]() |
Immunic CEO Dr Daniel Vitt on successful 2024, with more to come in the year ahead (Proactive Investors) View |
![]() |
Immunic CEO discusses New York MS Ru0026D Day, potential of vidofludimus calcium and MS studies (Proactive Investors) View |
![]() |
Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal (Proactive Investors) View |
![]() |
Immunic Inc. CEO Daniel Vitt Highlights Advances in MS Treatment on World MS Day (Proactive Investors) View |
![]() |
The TOP 3 Stocks That Will Make You Wealthy in 5 years MUST KNOW (SatoshiSwiss) View |